We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Aviptadil

News List

Biophore applies for DCGI approval for emergency use of Aviptadil to treat COVID-19 expresspharma
June 15, 2021
The company informed that it will be commencing commercial production immediately after the approval is received.
NRx Pharmaceuticals seeks FDA EUA for Covid-19 therapy Zyesami pharmaceutical-technology
June 03, 2021
NRx Pharmaceuticals has submitted an application to the US Food and Drug Administration (FDA) seeking Emergency Use Authorization (EUA) for Zyesami (Aviptadil-acetate) for the treatment of critically ill Covid-19 patients with respiratory failure.
Relief Therapeutics, NeuroRx File IND for Aviptadil for COVID-19-Induced Respiratory Distress americanpharmaceuticalreview
April 01, 2020
Relief Therapeutics and NeuroRx have filed an Investigational New Drug (IND) Application with the U.S. Food and Drug Administration (FDA) ...